BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 30689086)

  • 1. CGRP in Animal Models of Migraine.
    Wattiez AS; Wang M; Russo AF
    Handb Exp Pharmacol; 2019; 255():85-107. PubMed ID: 30689086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
    Tepper SJ
    Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
    Bigal ME; Walter S; Rapoport AM
    Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
    Maasumi K; Michael RL; Rapoport AM
    Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting calcitonin gene-related peptide: a new era in migraine therapy.
    Charles A; Pozo-Rosich P
    Lancet; 2019 Nov; 394(10210):1765-1774. PubMed ID: 31668411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic antibodies against CGRP or its receptor.
    Bigal ME; Walter S; Rapoport AM
    Br J Clin Pharmacol; 2015 Jun; 79(6):886-95. PubMed ID: 25614243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
    Edvinsson L
    Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin gene-related peptide: an update on the biology.
    Recober A; Russo AF
    Curr Opin Neurol; 2009 Jun; 22(3):241-6. PubMed ID: 19434786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A narrative review of the calcitonin peptide family and associated receptors as migraine targets: Calcitonin gene-related peptide and beyond.
    Garelja ML; Hay DL
    Headache; 2022 Oct; 62(9):1093-1104. PubMed ID: 36226379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain pharmacology in migraine: focus on CGRP and CGRP receptors.
    Benemei S; Nicoletti P; Capone JA; Geppetti P
    Neurol Sci; 2007 May; 28 Suppl 2():S89-93. PubMed ID: 17508187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CGRP: A New Era for Migraine Treatment.
    Wrobel Goldberg S; Silberstein SD
    CNS Drugs; 2015 Jun; 29(6):443-52. PubMed ID: 26138383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights into the Regulation of CGRP-Family Receptors.
    Gingell JJ; Hendrikse ER; Hay DL
    Trends Pharmacol Sci; 2019 Jan; 40(1):71-83. PubMed ID: 30527443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
    Edvinsson L; Haanes KA; Warfvinge K; Krause DN
    Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018.
    Tepper SJ
    Headache; 2018 Nov; 58 Suppl 3():276-290. PubMed ID: 30403405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin Gene-Related Peptide Antagonists and Therapeutic Antibodies.
    Rujan RM; Reynolds CA
    Handb Exp Pharmacol; 2019; 255():169-192. PubMed ID: 30689083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting.
    Wattiez AS; Sowers LP; Russo AF
    Expert Opin Ther Targets; 2020 Feb; 24(2):91-100. PubMed ID: 32003253
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists.
    Edvinsson L
    Expert Opin Ther Targets; 2007 Sep; 11(9):1179-88. PubMed ID: 17845144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CGRP/CGRP Receptor Antibodies: Potential Adverse Effects Due to Blockade of Neovascularization?
    Majima M; Ito Y; Hosono K; Amano H
    Trends Pharmacol Sci; 2019 Jan; 40(1):11-21. PubMed ID: 30502971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGRP and migraine: from bench to bedside.
    Edvinsson L
    Rev Neurol (Paris); 2021 Sep; 177(7):785-790. PubMed ID: 34275653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the brainstem in migraine: Potential brainstem effects of CGRP and CGRP receptor activation in animal models.
    Holland PR; Saengjaroentham C; Vila-Pueyo M
    Cephalalgia; 2019 Mar; 39(3):390-402. PubMed ID: 29411638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.